相关实验视频
Updated: Feb 4, 2026

08:43
Orthotopic Mouse Model of Colorectal Cancer
Published on: December 4, 2007
47.2K
Scorpio fuscus 毒液作为一种有前途的抗癌剂,可以对抗结直肠癌
Serdar Karakurt1,2, Cigdem Gokcek-Sarac3, Sinan Kandir4
1Department of Biochemistry, Faculty of Science, Selcuk University, Konya, Türkiye. karakurt@selcuk.edu.tr.
Investigational new drugs
|February 2, 2026
概括
黄 (Scorpio fuscus) 毒 (SFV) 对结直肠癌模型显示出显著的抗癌作用. 这种天然化合物减少了瘤生长和癌细胞活力,提供了一个有前途的替代疗法.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题,治疗选择有限.
- 传统的CRC疗法具有显著的副作用,需要新的治疗策略.
- Scorpio fuscus 毒液 (SFV) 被探索为抗癌剂的潜在来源.
研究的目的:
- 评估Scorpio fuscus毒液 (SFV) 对人类结直肠癌的体外和体内抗癌作用.
- 描述SFV成分并分析它们与癌症相关蛋白质的相互作用.
- 评估SFV对结直肠癌细胞活力,迁移,殖民地形成和亡的影响.
主要方法:
- 使用凝电泳,HPLC和UV-VIS光谱学分析了SFV成分.
- 在基分析中进行了质结构和蛋白质对接.
- 细胞毒性在CRC细胞系 (DLD-1,HT-29,CaCo-2) 和正常细胞系 (CCD-18Co) 中使用Alamar Blue试验进行了评估.
- 在体内研究中使用了皮下和正管老鼠异种移植模型.
- 亡,基因表达和瘤标志物通过流细胞计,基因表达分析和免疫组织化学分析.
主要成果:
- SFV对CRC细胞系表现出剂量依赖的细胞毒性,降低了活力,迁移和殖民地形成.
- SFV治疗调节了与亡相关的基因,并在体内改变了与瘤相关的标记物表达.
- 在皮下和正管小鼠模型中,SFV显著抑制了瘤生长.
- 基因表达造型揭示了关键细胞亡和细胞存活途径的显著变化.
结论:
- 黄 (Scorpio fuscus) 毒 (SFV) 在体外和体内都对结直肠癌表现出强大的抗瘤活性.
- SFV显示出作为结直肠癌治疗的新型治疗剂的潜力.
- 需要进一步的研究来阐明SFV的作用机制及其转化潜力.
相关概念视频
Subviral Agents
565
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
565
Air-entraining Agents
272
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
272
Masking and Demasking Agents
3.6K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.6K
Spasmolytic Agents: Chemical Classification
1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
Oral Hypoglycemic Agents: Glinides
664
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
664
Anticholinesterase Agents: Poisoning and Treatment
1.6K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.6K

